Admission Date:  [**2131-8-15**]              Discharge Date:   [**2131-9-6**]  Date of Birth:  [**2108-7-3**]             Sex:   F  Service: MEDICINE  Allergies: Vicodin / pears  Attending:[**First Name3 (LF) 3918**] Chief Complaint: Easy bruising, malaise, bony pain, concern for leukemia  Major Surgical or Invasive Procedure: Central line placement LP with IT chemo x 2  History of Present Illness: 23yoF with h/o asthma and ADHD who is being admitted out of concern for acute leukemia.
She again presented to the ED on [**7-14**] with similar complaints and began taking ibuprofen for the pain.
Over the course of the past month she has experienced worsening sweating - at night and during the day, worsening fatigue, bilateral arm heaviness, easy bruising, and petechial rash on her arms and legs.
Past Medical History: ADHD Asthma - uses albuterol 2x per week since age 13 Depression Anxiety   Social History: Lives in [**Location 10022**], MA with her grandmother and grandfather.
tob: 0.5 ppd x 3 years (quit last Saturday) EtOH: 1 beer per week illicits: none   Family History: Mother - epilepsy [**Name (NI) **] Aunt: [**Name (NI) 4278**] lymphoma Ma GPa: [**Name (NI) 2320**] Father - doesn't know about father's health   Physical Exam: Physical Exam on admission: VS - 100.0 111 120/88 20 96% on RA GENERAL - overweight female w/ cold compress on forehead, pleasant, a&ox3, diaphoretic, NAD HEENT - wearing color contacts so difficult to assess pupils, EOMI, sclerae anicteric, MMM, OP clear NECK - supple, no thyromegaly, no JVD LUNGS - CTA bilat, no r/rh/wh HEART - tachycardic, regular, no MRG, nl S1-S2 ABDOMEN - obese abdomen, NABS, soft/NT/ND, difficult to assess for hepatosplenomegaly EXTREMITIES - WWP, no c/c/e, 2+ peripheral pulses (radials, DPs)  SKIN - petechial rash on arms and legs, tattoo on back, extensive brusing on bilateral UE NEURO - awake, A&Ox3, CNs II-XII grossly intact, muscle strength [**5-10**] throughout, sensation grossly intact throughout, DTRs 2+ and symmetric, cerebellar exam intact  Physical Exam on Discharge: Patient was afebrile on discharge.
HEART: RRR, no M/R/G CHEST: occlusive dressing on wound from central line removal Exam otherwise unchanged from admission EXTREMITIES: no bruising or petechiae  Pertinent Results: ADMISSION LABS  [**2131-8-15**] 04:00PM BLOOD WBC-12.8* RBC-3.55* Hgb-11.3* Hct-29.8* MCV-84 MCH-31.9 MCHC-38.0* RDW-13.5 Plt Ct-21* [**2131-8-15**] 04:00PM BLOOD Neuts-15* Bands-1 Lymphs-25 Monos-1* Eos-0 Baso-0 Atyps-0 Metas-1* Myelos-0 Blasts-57* Other-0 [**2131-8-15**] 04:00PM BLOOD Hypochr-1+ Anisocy-OCCASIONAL Poiklo-NORMAL Macrocy-NORMAL Microcy-NORMAL Polychr-NORMAL [**2131-8-15**] 04:00PM BLOOD PT-13.9* PTT-40.0* INR(PT)-1.2* [**2131-8-15**] 04:00PM BLOOD Fibrino-727* [**2131-8-15**] 04:00PM BLOOD Ret Aut-1.1* [**2131-8-15**] 04:00PM BLOOD Glucose-109* UreaN-7 Creat-0.6 Na-130* K-3.8 Cl-92* HCO3-29 AnGap-13 [**2131-8-15**] 04:00PM BLOOD ALT-24 AST-30 LD(LDH)-617* AlkPhos-85 TotBili-1.0 [**2131-8-15**] 04:00PM BLOOD Albumin-4.0 Calcium-9.6 Phos-5.6* Mg-1.6 UricAcd-5.1 [**2131-8-17**] 03:05PM BLOOD Triglyc-120 HDL-15 CHOL/HD-8.7 LDLcalc-91 LDLmeas-66 [**2131-8-17**] 03:05PM BLOOD TSH-3.5 [**2131-8-17**] 03:05PM BLOOD HCG-<5  BCX, UCX, CSF GRAM STAIN: Negative  FLOW CYTOMETRY: RESULTS:  Cell marker analysis demonstrates that a majority of the cells isolated from this peripheral blood are in the CD45-dim-to-moderate, low side-scatter, 'blast gate'.
BONE MARROW: SPECIMEN: BONE MARROW ASPIRATE AND CORE BIOPSY:  DIAGNOSIS: Acute lymphoblastic leukemia, see note.
Erythrocytes appear mildly decreased in number, are normochromic with rare dacryocytes, echinocytes, fragments,  microcytes and nucleated red blood cells noted.
The smears are hypercellular with sheets of small to medium sized cells, with scant cytoplasm, smooth chromatin, prominent nucleoli and slightly irregular nuclear contours, morphologically consistent with blasts Clot Section and Biopsy Slides:  The biopsy material is adequate for evaluation and consists of two bone marrow core biopsies composed of trabecular bone with bone marrow elements, the overall cellularity is more than 95% and consists almost entirely of a monotonous population of variably-sized cells with round to regular nuclei, open chromatin and scant amount of cytoplasm.
CSF: [**2131-8-18**] 03:38PM CEREBROSPINAL FLUID (CSF) WBC-1 RBC-7* Polys-0 Lymphs-56 Monos-44 [**2131-8-18**] 03:38PM CEREBROSPINAL FLUID (CSF) TotProt-20 Glucose-62 LD(LDH)-17 [**2131-9-1**] 07:01PM CEREBROSPINAL FLUID (CSF) WBC-1 RBC-1* Polys-2 Lymphs-62 Monos-36  [**8-18**] immunophenotyping of CSF: No aberrant cells are identified in this specimen using a limited marker panel.
She underwent induction chemotherapy under experimental protcol #06-254 ALL Adult Consortium trial.
The protocol included PO prednisone, and IV doxorubicin, cytarabine, vincristine, and methotrexate.
She also received intrathecal methotrexate, cytarabine, and hydrocortisone.
The protocol included asparaginase as well.
She received enoxaparin for DVT prophylaxis, and zofran and compazine for nausea.
She was given acyclovir and fluconazole for infection prophylaxis while neutropenic and received a 10-day course of IV cefepime for fever on admission that was culture-negative.
Patient's neutrophil count dropped with therapy but recovered.
She was instructed to follow up on day 22 next for IV vincristine  2.
Atrial fibrillation: Patient experienced new onset atrial fibrillation with RVR in the hospital after a placement of a central line.
Asthma: Patient was continued on home albuterol inhaler prn.
Depression: Patient was continued on home venlafaxine.
Transitions in Care: Patient was given a follow-up appointment 2 days post-discharge for IV chemotherapy and blood work, and given an appointment on [**2131-9-14**] for further chemo and BM biopsy.
She was instructed to stop taking Lovenox >24 hours before the procedure.
Medications on Admission: Albuterol prn Adderall 30 mg [**Hospital1 **] venlafaxine XR 75 mg qday ibuprofen prn   Discharge Medications: 1. prednisone 10 mg Tablet Sig: 4.5 Tablets PO BID (2 times a day) for 10 days.
Disp:*90 Tablet(s)* Refills:*0* 2. acyclovir 400 mg Tablet Sig: One (1) Tablet PO TID (3 times a day).
Disp:*90 Tablet(s)* Refills:*2* 3. enoxaparin 40 mg/0.4 mL Syringe Sig: One (1) unit Subcutaneous DAILY (Daily): Last day is day 26 ([**2131-9-12**]).
)(s)* Refills:*2* 6. oxycodone 5 mg Tablet Sig: One (1) Tablet PO every six (6) hours as needed for pain.
Disp:*30 Tablet(s)* Refills:*0* 7. albuterol sulfate 90 mcg/Actuation HFA Aerosol Inhaler Sig: 1-2 puffs Inhalation every 4-6 hours as needed for shortness of breath or wheezing.
Disp:*1 inhaler* Refills:*1* 8. venlafaxine 75 mg Capsule, Ext Release 24 hr Sig: One (1) Capsule, Ext Release 24 hr PO once a day.
Discharge Instructions: Dear Ms. [**Known lastname 91125**],  You were admitted to the hospital for chemotherapy for newly diagnosed leukemia.
You completed the first stage of your chemotherapy and are ready to go home to continue therapy as an outpatient.
START Enoxaparin 40mg by subcutaneous injection daily, and STOP taking it after your dose on Wednesday, [**9-12**].
START Prednisone 45mg by mouth twice daily through [**9-14**] 6.
START Vitamin D3 400units by mouth daily 7.
STOP taking venlafaxine until further instructed  Please continue taking all other medications as previously prescribed to you.
Please return to clinic as instructed to complete your course of chemotherapy, and for scheduled bone marrow biopsy.
Followup Instructions: [**2131-9-8**] at 10:30AM-Please go to your appointment at 7 [**Hospital Ward Name 1826**] Outpatient Clinic for chemotherapy and labs.
